Literature DB >> 11241883

Perinatal brain injury: from pathogenesis to neuroprotection.

J J Volpe1.   

Abstract

Brain injury secondary to hypoxic-ischemic disease is the predominant form of all brain injury encountered in the perinatal period. The focus of this article is the most recent research developments in this field and especially those developments that should lead to the most profound effects on interventions in the first years of the new millennium. Neuronal injury is the predominant form of cellular injury in the term infant. The principal mechanisms leading to neuronal death after hypoxia-ischemia/reperfusion are initiated by energy depletion, accumulation of extracellular glutamate, and activation of glutamate receptors. The cascade of events that follows involves accumulation of cytosolic calcium and activation of a variety of calcium-mediated deleterious events. Notably this deleterious cascade, which evolves over many hours, may be interrupted even if interventions are instituted after termination of the insult, an important clinical point. Of the potential interventions, the leading candidates for application to the human infant in the relative short-term are mild hypothermia, inhibitors of free radical production, and free radical scavengers. Promising clinical data are available for the use of mild hypothermia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241883     DOI: 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN: 1080-4013


  128 in total

Review 1.  Protecting motor networks during perinatal ischemia: the case for delta-opioid receptors.

Authors:  Stephen M Johnson; Sara M F Turner
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

2.  Osteopontin reduced hypoxia-ischemia neonatal brain injury by suppression of apoptosis in a rat pup model.

Authors:  Wanqiu Chen; Qingyi Ma; Hidenori Suzuki; Richard Hartman; Jiping Tang; John H Zhang
Journal:  Stroke       Date:  2011-01-27       Impact factor: 7.914

3.  Injury and repair in developing brain.

Authors:  F M Vaccarino; L R Ment
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-05       Impact factor: 5.747

4.  A novel approach to the study of hypoxia-ischemia-induced clinical and subclinical seizures in the neonatal rat.

Authors:  M Cuaycong; M Engel; S L Weinstein; E Salmon; J M Perlman; S Sunderam; S J Vannucci
Journal:  Dev Neurosci       Date:  2011-09-27       Impact factor: 2.984

5.  Role of the pituitary–adrenal axis in granulocyte-colony stimulating factor-induced neuroprotection against hypoxia–ischemia in neonatal rats.

Authors:  Mélissa S Charles; Robert P Ostrowski; Anatol Manaenko; Kamil Duris; John H Zhang; Jiping Tang
Journal:  Neurobiol Dis       Date:  2012-07       Impact factor: 5.996

6.  Ischemic Conditioning and neonatal hypoxic ischemic encephalopathy: a literature review.

Authors:  Dusit Adstamongkonkul; David C Hess
Journal:  Cond Med       Date:  2017-12-15

7.  17alpha-Estradiol is neuroprotective in male and female rats in a model of early brain injury.

Authors:  Jacob McClean; Joseph L Nuñez
Journal:  Exp Neurol       Date:  2007-10-10       Impact factor: 5.330

8.  Abnormal heart rate characteristics are associated with abnormal neuroimaging and outcomes in extremely low birth weight infants.

Authors:  K D Fairchild; R A Sinkin; F Davalian; A E Blackman; J R Swanson; J A Matsumoto; D E Lake; J R Moorman; J A Blackman
Journal:  J Perinatol       Date:  2014-02-20       Impact factor: 2.521

9.  Predictors of neurodevelopmental outcome for preterm infants with brain injury: MRI, medical and environmental factors.

Authors:  Lina Kurdahi Badr; Susan Bookheimer; Isabell Purdy; Mary Deeb
Journal:  Early Hum Dev       Date:  2009-01-11       Impact factor: 2.079

10.  Critical role of neuronal pentraxin 1 in mitochondria-mediated hypoxic-ischemic neuronal injury.

Authors:  Md Al Rahim; Shabarish Thatipamula; Mir Ahamed Hossain
Journal:  Neurobiol Dis       Date:  2012-10-12       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.